STRATA Skin Sciences to Present at the H.C. Wainwright Bioconnect Virtual Conference
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced participation in the H.C. Wainwright Bioconnect Virtual Conference, with a pre-recorded presentation set for January 10, 2022, at 7:00 am ET. The presentation will be accessible via the investor section of their website. STRATA focuses on innovative dermatology treatments, offering products like XTRAC and Pharos excimer lasers, which treat skin conditions affecting over 31 million patients in the U.S. Their strategy includes direct-to-consumer advertising to boost awareness and support partner clinics through in-house services.
- None.
- None.
HORSHAM, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that members of Management will participate in the upcoming H.C. Wainwright Bioconnect Virtual Conference.
A Pre-recorded presentation will be available on Monday, January 10th at 7:00 am Eastern Time. Interested parties may access a webcast of the presentation on the investor section of the Company’s website www.strataskinsciences.com.
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company in dermatology dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® and Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.
The Company’s proprietary XTRAC and recently acquired Pharos excimer lasers deliver a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. The technology is covered by multiple patents.
STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.
Investor Contact
Jack Droogan |
(203) 585-4140 |
ir@strataskin.com |
FAQ
When is STRATA Skin Sciences' virtual presentation for the H.C. Wainwright Bioconnect Conference?
Where can I access the STRATA Skin Sciences presentation?
What are the main products offered by STRATA Skin Sciences?
How does STRATA Skin Sciences reach customers?